Having received two doses of hepatitis B vaccine and an anti‑HBs titer of 166 mIU/mL (reactive), should I complete the series with a third dose or only receive a booster?

Complete the Series with a Third Dose

With an anti-HBs titer of 166 mIU/mL after two doses, you are already well-protected and do not need any additional vaccination at this time—neither a third dose to complete the series nor a booster. Your antibody level far exceeds the protective threshold of ≥10 mIU/mL 1.

Understanding Your Current Status

Your titer of 166 mIU/mL indicates:

• You are fully protected against hepatitis B infection
• You have mounted a robust immune response to just two doses
• You have established immunologic memory

The protective threshold is ≥10 mIU/mL, and you are more than 16-fold above this level 1, 2.

Why You Don't Need a Third Dose Now

Standard Series Completion

While the typical hepatitis B vaccine series consists of 3 doses given at 0,1, and 6 months 3, the goal of vaccination is to achieve protective antibody levels and establish immune memory—not simply to complete a predetermined number of doses.

Research demonstrates that:

• Two doses given 6 months apart can induce protective antibody responses in 97-99% of young adults 4
• Immune memory persists even when antibody titers decline over time 5
• Protection depends on immune memory rather than maintaining high antibody levels 5

The Interrupted Series Guideline

According to ACIP guidelines, if a hepatitis B vaccine schedule is interrupted, the series does not need to be restarted 1. The key principle is that each dose contributes to immunity, and there's no need to repeat doses or adhere rigidly to the schedule when adequate protection has been achieved.

Practical Recommendations

For immunocompetent individuals (most people):

• No further vaccination needed now
• No routine antibody testing required in the future
• You have long-term protection (>10 years) 6
• Booster doses are unnecessary 5

Special circumstances requiring consideration:

If you fall into any of these categories, you may want to complete the third dose:

• Healthcare workers or public safety workers with occupational blood/body fluid exposure risk 1
• Hemodialysis patients (require annual anti-HBs monitoring) 1
• Immunocompromised persons (HIV-positive, chemotherapy, transplant recipients) 1
• Sexual partners of HBsAg-positive persons 1

For these high-risk groups, completing the standard 3-dose series ensures optimal and more durable antibody responses, even though you're currently protected.

Common Pitfalls to Avoid

1. Don't confuse "completing the series" with "achieving protection"—you already have protection
2. Don't get unnecessary boosters—immunocompetent persons with documented adequate response don't need them 5
3. Don't retest antibodies routinely—unless you're in a high-risk category requiring monitoring 1

If You Choose to Complete the Series

If you're in a high-risk occupation or prefer to complete the standard series for documentation purposes:

• Give the third dose at least 8 weeks after your second dose 1
• The third dose should be at least 16 weeks after the first dose 1
• This will likely boost your antibody levels even higher (GMTs of 2,000-5,000+ mIU/mL are typical after three doses) 2

Bottom line: Your current antibody level of 166 mIU/mL provides excellent protection. For most people, no further action is needed.